Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01534247 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT01534247 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 28 participants.
The verdict
NCT01534247, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of the study is to assess whether there is any pharmacokinetic interactions between CAZ-AVI and metronidazole.
Interventions
- DRUG metronidazole
- DRUG CAZ-AVI
- DRUG CAZ-AVI + metronidazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01534247
The ClinicalTrials.gov registry entry for NCT01534247 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which metronidazole is the first listed.
NCT01534247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01534247 about?
NCT01534247 is a clinical study titled "A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately". The purpose of the study is to assess whether there is any pharmacokinetic interactions between CAZ-AVI and metronidazole.
What is the current status of trial NCT01534247?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2012-02. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01534247?
The interventions under investigation include: metronidazole (DRUG), CAZ-AVI (DRUG), CAZ-AVI + metronidazole (DRUG).
Who is sponsoring clinical trial NCT01534247?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.